The blood–brain barrier and blood–tumour barrier in brain tumours and metastases

[1]  J. Sampson,et al.  Brain immunology and immunotherapy in brain tumours , 2019, Nature Reviews Cancer.

[2]  L. Zon,et al.  Tumor-Derived Extracellular Vesicles Breach the Intact Blood Brain Barrier via Transcytosis. , 2019, ACS nano.

[3]  T. Kuner,et al.  Glutamatergic synaptic input to glioma cells drives brain tumour progression , 2019, Nature.

[4]  Shawn M. Gillespie,et al.  Electrical and synaptic integration of glioma into neural circuits , 2019, Nature.

[5]  S. Ayloo,et al.  Transcytosis at the blood–brain barrier , 2019, Current Opinion in Neurobiology.

[6]  Inti Zlobec,et al.  Synaptic proximity enables NMDAR signaling to promote brain metastasis , 2019, Nature.

[7]  Arpit Patel,et al.  Closed-Loop Spatial and Temporal Control of Cavitation Activity With Passive Acoustic Mapping , 2019, IEEE Transactions on Biomedical Engineering.

[8]  S. Triarico,et al.  Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors , 2019, Cancers.

[9]  R. Weissleder,et al.  Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy. , 2019, ACS nano.

[10]  Arthur André,et al.  Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma , 2019, Clinical Cancer Research.

[11]  L. Sevenich.  Turning “Cold” Into “Hot” Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers , 2019, Front. Oncol..

[12]  Kullervo Hynynen,et al.  Advances in acoustic monitoring and control of focused ultrasound-mediated increases in blood-brain barrier permeability. , 2019, The British journal of radiology.

[13]  Thomas Lars Andresen,et al.  Modulating the antibody density changes the uptake and transport at the blood‐brain barrier of both transferrin receptor‐targeted gold nanoparticles and liposomal cargo , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[14]  A. L. Allegra Mascaro,et al.  Astrocytic endfeet re-cover blood vessels after removal by laser ablation , 2019, Scientific Reports.

[15]  R. Jain,et al.  Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategies , 2019, Proceedings of the National Academy of Sciences.

[16]  K. Hynynen,et al.  Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study , 2019, Scientific Reports.

[17]  Dawen Zhao,et al.  MRI evaluation of the effects of whole brain radiotherapy on breast cancer brain metastasis , 2019, International journal of radiation biology.

[18]  P. Wen,et al.  Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma , 2018, Nature Medicine.

[19]  Tracy T Batchelor,et al.  Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium , 2018, Nature Biomedical Engineering.

[20]  Mark E. Davis,et al.  Method of establishing breast cancer brain metastases affects brain uptake and efficacy of targeted, therapeutic nanoparticles , 2018, Bioengineering & translational medicine.

[21]  Shawez Khan,et al.  EndoDB: a database of endothelial cell transcriptomics data , 2018, Nucleic Acids Res..

[22]  Steven D Chang,et al.  Brain metastases. , 2019, Nature reviews. Disease primers.

[23]  B. Zlokovic,et al.  Blood-Brain Barrier: From Physiology to Disease and Back. , 2019, Physiological reviews.

[24]  M. Gilbert,et al.  Immunotherapy in CNS cancers: the role of immune cell trafficking , 2019, Neuro-oncology.

[25]  R. Boellaard,et al.  Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer , 2018, Nature Communications.

[26]  Loyal A Goff,et al.  Transcriptional and epigenomic landscapes of CNS and non-CNS vascular endothelial cells , 2018, eLife.

[27]  P. Varlet,et al.  Imaging features of medulloblastoma: Conventional imaging, diffusion-weighted imaging, perfusion-weighted imaging, and spectroscopy: From general features to subtypes and characteristics. , 2018, Neuro-Chirurgie.

[28]  Costas D. Arvanitis,et al.  Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood–tumor barrier disruption , 2018, Proceedings of the National Academy of Sciences.

[29]  K. Aboody,et al.  Concise Review: Neural Stem Cell‐Mediated Targeted Cancer Therapies , 2018, Stem cells translational medicine.

[30]  Ying Sun,et al.  Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types , 2018, Scientific Data.

[31]  Evan Z. Macosko,et al.  Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain , 2018, Cell.

[32]  F. Gleeson,et al.  Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial , 2018, The Lancet. Oncology.

[33]  K. Yagi,et al.  Angubindin‐1 opens the blood–brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[34]  P. Brastianos,et al.  Reactive astrocytic S1P3 signaling modulates the blood–tumor barrier in brain metastases , 2018, Nature Communications.

[35]  J. Sarkaria,et al.  Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine , 2018, Pharmaceutical Research.

[36]  C. Bettegowda,et al.  Current state of immunotherapy for glioblastoma , 2018, Nature Reviews Clinical Oncology.

[37]  Katrina H. Smith,et al.  Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma , 2018, Clinical Cancer Research.

[38]  G. Rao,et al.  Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a , 2018, Scientific Reports.

[39]  J. Beijnen,et al.  Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG21 , 2018, Neoplasia.

[40]  M. Oldham,et al.  A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment. , 2018, Cancer cell.

[41]  M. Gottesman,et al.  Revisiting the role of ABC transporters in multidrug-resistant cancer , 2018, Nature Reviews Cancer.

[42]  Chenghua Gu,et al.  Bridging barriers: a comparative look at the blood–brain barrier across organisms , 2018, Genes & development.

[43]  Steven J. M. Jones,et al.  The Immune Landscape of Cancer , 2018, Immunity.

[44]  Triantafyllos Stylianopoulos,et al.  Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside. , 2018, Trends in cancer.

[45]  M. Sanson,et al.  ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma , 2018, Journal of Neuro-Oncology.

[46]  P. Brastianos,et al.  The Evolving Landscape of Brain Metastasis. , 2018, Trends in cancer.

[47]  Koji Ando,et al.  A molecular atlas of cell types and zonation in the brain vasculature , 2018, Nature.

[48]  E. Winer,et al.  Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain? , 2018, Clinical Cancer Research.

[49]  D. Reardon,et al.  Concepts for Immunotherapies in Gliomas , 2018, Seminars in Neurology.

[50]  Leland S. Hu,et al.  Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data , 2018, Neuro-oncology.

[51]  R. Magge,et al.  Advances in Radiotherapy for Glioblastoma , 2018, Front. Neurol..

[52]  Matthew D. Hellmann,et al.  Immune‐Related Adverse Events Associated with Immune Checkpoint Blockade , 2018, The New England journal of medicine.

[53]  B. Badie,et al.  Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[54]  E. Eppler,et al.  Microglia at center stage: a comprehensive review about the versatile and unique residential macrophages of the central nervous system , 2017, Oncotarget.

[55]  J. Schuetz,et al.  Obstacles to Brain Tumor Therapy: Key ABC Transporters , 2017, International journal of molecular sciences.

[56]  Chanikarn Power,et al.  Closed-loop control of targeted ultrasound drug delivery across the blood–brain/tumor barriers in a rat glioma model , 2017, Proceedings of the National Academy of Sciences.

[57]  Jennifer S. Yu,et al.  Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy. , 2017, Cell stem cell.

[58]  G. Ciofani,et al.  Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[59]  Yue Cao,et al.  Blood-tumor barrier opening changes in brain metastases from pre to one-month post radiation therapy. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[60]  C. Iadecola.  The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease , 2017, Neuron.

[61]  N. Sanai,et al.  Quantitative and Mechanistic Understanding of AZD1775 Penetration across Human Blood–Brain Barrier in Glioblastoma Patients Using an IVIVE–PBPK Modeling Approach , 2017, Clinical Cancer Research.

[62]  Kullervo Hynynen,et al.  Acute Inflammatory Response Following Increased Blood-Brain Barrier Permeability Induced by Focused Ultrasound is Dependent on Microbubble Dose , 2017, Theranostics.

[63]  N. Saunders,et al.  Brain barriers and functional interfaces with sequential appearance of ABC efflux transporters during human development , 2017, Scientific Reports.

[64]  K. Yagi,et al.  Angubindin‐1, a novel paracellular absorption enhancer acting at the tricellular tight junction , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[65]  Colleen T. Curley,et al.  Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities , 2017, Theranostics.

[66]  E. Barbier,et al.  Permeability of Brain Tumor Vessels Induced by Uniform or Spatially Microfractionated Synchrotron Radiation Therapies. , 2017, International journal of radiation oncology, biology, physics.

[67]  T. Moos,et al.  The vascular basement membrane in the healthy and pathological brain , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[68]  M. Sofroniew,et al.  Astrocytic tight junctions control inflammatory CNS lesion pathogenesis , 2017, The Journal of clinical investigation.

[69]  Miles A. Miller,et al.  Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts , 2017, Science Translational Medicine.

[70]  C. Miller,et al.  The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation , 2017, Science Translational Medicine.

[71]  Michael R. Taylor,et al.  CNS angiogenesis and barriergenesis occur simultaneously. , 2017, Developmental biology.

[72]  H. Phillips,et al.  Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis , 2017, Breast Cancer Research and Treatment.

[73]  Nadim Jon Shah,et al.  Advances in neuro-oncology imaging , 2017, Nature Reviews Neurology.

[74]  L. Velloso,et al.  Development and Function of the Blood-Brain Barrier in the Context of Metabolic Control , 2017, Front. Neurosci..

[75]  C. Iadecola,et al.  Size-selective opening of the blood–brain barrier by targeting endothelial sphingosine 1–phosphate receptor 1 , 2017, Proceedings of the National Academy of Sciences.

[76]  Nathan McDannold,et al.  Passive Acoustic Mapping with the Angular Spectrum Method , 2017, IEEE Transactions on Medical Imaging.

[77]  N. McDannold,et al.  Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound‐induced blood‐tumor barrier disruption , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[78]  D. Quail,et al.  The Microenvironmental Landscape of Brain Tumors. , 2017, Cancer cell.

[79]  Howard Y. Chang,et al.  Gpr124 is essential for blood–brain barrier integrity in central nervous system disease , 2017, Nature Medicine.

[80]  P. Hamilton,et al.  Regulatory T cells promote myelin regeneration in the Central Nervous System , 2017, Nature Neuroscience.

[81]  Binbin Xie,et al.  Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis , 2017, Oncotarget.

[82]  S. Gambhir,et al.  Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma , 2017, Science Translational Medicine.

[83]  Marco Prinz,et al.  The role of peripheral immune cells in the CNS in steady state and disease , 2017, Nature Neuroscience.

[84]  D. Jaffray,et al.  Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery☆ , 2017, Advanced drug delivery reviews.

[85]  Luca Cucullo,et al.  New experimental models of the blood-brain barrier for CNS drug discovery , 2017, Expert opinion on drug discovery.

[86]  M. Souweidane,et al.  Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment , 2016, Current neuropharmacology.

[87]  Ian Law,et al.  The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy , 2016, NeuroImage: Clinical.

[88]  M. Aghi,et al.  Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies. , 2017, Journal of neurosurgery.

[89]  Jennifer I. Hare,et al.  Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. , 2017, Advanced drug delivery reviews.

[90]  K. Nałęcz.  Solute Carriers in the Blood–Brain Barier: Safety in Abundance , 2016, Neurochemical Research.

[91]  Xiuli Wang,et al.  Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. , 2016, The New England journal of medicine.

[92]  Neekita Jikaria,et al.  Disrupting the blood–brain barrier by focused ultrasound induces sterile inflammation , 2016, Proceedings of the National Academy of Sciences.

[93]  P. Frankel,et al.  Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients , 2016, Clinical Cancer Research.

[94]  Neno T Pokrajac,et al.  Norrin/Frizzled4 signalling in the preneoplastic niche blocks medulloblastoma initiation , 2016, eLife.

[95]  N. Ibrahim,et al.  ANG1005, a novel peptide-paclitaxel conjugate crosses the BBB and shows activity in patients with recurrent CNS metastasis from breast cancer, results from a phase II clinical study , 2016 .

[96]  Jun S. Liu,et al.  Comprehensive analyses of tumor immunity: implications for cancer immunotherapy , 2016, Genome Biology.

[97]  W. Wick,et al.  Impact of Blood–Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases , 2016, Clinical Cancer Research.

[98]  K. Hoang-Xuan,et al.  Clinical trial of blood-brain barrier disruption by pulsed ultrasound , 2016, Science Translational Medicine.

[99]  S. Steinberg,et al.  Alterations in Pericyte Subpopulations Are Associated with Elevated Blood–Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer , 2016, Clinical Cancer Research.

[100]  E. Winer,et al.  Combination inhibition of PI3K and mTORC1 yields durable remissions in orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases , 2016, Nature Medicine.

[101]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[102]  M. Roussel,et al.  Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype. , 2016, Cancer cell.

[103]  S. Liebner,et al.  Blood-Brain Barrier Breakdown Determines Differential Therapeutic Outcome in Genetically Diverse Forms of Medulloblastoma. , 2016, Cancer cell.

[104]  V. Préat,et al.  Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[105]  R. Jain,et al.  Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment. , 2016, Journal of the National Cancer Institute.

[106]  W. Banks,et al.  From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery , 2016, Nature Reviews Drug Discovery.

[107]  R. Keep,et al.  Junctional proteins of the blood-brain barrier: New insights into function and dysfunction , 2016, Tissue barriers.

[108]  C. Greene,et al.  Tight junction modulation of the blood brain barrier: CNS delivery of small molecules , 2016, Tissue barriers.

[109]  J. Lübke,et al.  Influence of blood-brain barrier permeability on O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[110]  J. Sarkaria,et al.  Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma. , 2016, Neuro-oncology.

[111]  G. Bergers,et al.  Glioblastoma: Defining Tumor Niches. , 2015, Trends in cancer.

[112]  Zhen Zhao,et al.  Establishment and Dysfunction of the Blood-Brain Barrier , 2015, Cell.

[113]  Naoya Hashimoto,et al.  Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. , 2015, The Lancet. Oncology.

[114]  Triantafyllos Stylianopoulos,et al.  Design considerations for nanotherapeutics in oncology. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[115]  Patrick J. Paddison,et al.  CNS Anticancer Drug Discovery and Development Conference White Paper. , 2015, Neuro-oncology.

[116]  Chenghua Gu,et al.  The Molecular Constituents of the Blood–Brain Barrier , 2015, Trends in Neurosciences.

[117]  Steffen Jung,et al.  Microglia Plasticity During Health and Disease: An Immunological Perspective. , 2015, Trends in immunology.

[118]  R. McLendon,et al.  Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma , 2015, Clinical Cancer Research.

[119]  Stephen Meairs,et al.  Facilitation of Drug Transport across the Blood–Brain Barrier with Ultrasound and Microbubbles , 2015, Pharmaceutics.

[120]  Shenglin Ma,et al.  Whole-brain radiation fails to boost intracerebral gefitinib concentration in patients with brain metastatic non-small cell lung cancer: a self-controlled, pilot study , 2015, Cancer Chemotherapy and Pharmacology.

[121]  Shibing Deng,et al.  PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models. , 2015, Cancer cell.

[122]  A. Chambers,et al.  Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and Therapy , 2015, Translational oncology.

[123]  Britta Engelhardt,et al.  Brain barriers: Crosstalk between complex tight junctions and adherens junctions , 2015, The Journal of cell biology.

[124]  Graham E Searle,et al.  Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer , 2015, EJNMMI Research.

[125]  I. Sarelius,et al.  Control of vascular permeability by adhesion molecules , 2015, Tissue barriers.

[126]  Yusuke Yoshioka,et al.  Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier , 2015, Nature Communications.

[127]  P. Foster,et al.  In-vivo longitudinal MRI study: an assessment of melanoma brain metastases in a clinically relevant mouse model , 2015, Melanoma research.

[128]  Malisa Sarntinoranont,et al.  Convection-enhanced delivery to the central nervous system. , 2015, Journal of neurosurgery.

[129]  T. Wurdinger,et al.  Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[130]  R. Jain,et al.  Emerging strategies for treating brain metastases from breast cancer. , 2015, Cancer cell.

[131]  Weidong Wei,et al.  Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy , 2015, Oncotarget.

[132]  R. Weil,et al.  Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study. , 2015, Neuro-oncology.

[133]  T. Ryken,et al.  Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis , 2015, Journal of Neuro-Oncology.

[134]  E. Shusta,et al.  Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier. , 2015, Annual review of pharmacology and toxicology.

[135]  Nathan McDannold,et al.  Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system , 2014, Defense + Security Symposium.

[136]  R. Daneman,et al.  The blood-brain barrier. , 2015, Cold Spring Harbor perspectives in biology.

[137]  Norman R. Saunders,et al.  The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history , 2014, Front. Neurosci..

[138]  Vivaldo Moura-Neto,et al.  Gliomas and the vascular fragility of the blood brain barrier , 2014, Front. Cell. Neurosci..

[139]  M. Aghi,et al.  Molecularly targeted therapies for recurrent glioblastoma: current and future targets. , 2014, Neurosurgical focus.

[140]  Joanna M. Wardlaw,et al.  Assessment of blood–brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review , 2014, NeuroImage: Clinical.

[141]  Khalid Shah,et al.  Stem cell-based therapies for cancer treatment: separating hope from hype , 2014, Nature Reviews Cancer.

[142]  W. Hahn,et al.  Analysis of tumor- and stroma-supplied proteolytic networks reveals a brain metastasis-promoting role for cathepsin S , 2014, Nature Cell Biology.

[143]  T. Dresselaers,et al.  In vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal models , 2014, Journal of Neuro-Oncology.

[144]  K. Yeom,et al.  MRI Surrogates for Molecular Subgroups of Medulloblastoma , 2014, American Journal of Neuroradiology.

[145]  Harald Sontheimer,et al.  Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells , 2014, Nature Communications.

[146]  Yoav Mayshar,et al.  Mfsd2a is critical for the formation and function of the blood–brain barrier , 2014, Nature.

[147]  J. Kreuter,et al.  Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? , 2014, Advanced drug delivery reviews.

[148]  S. Rivest,et al.  The Role of Pericytes in Neurovascular Unit Remodeling in Brain Disorders , 2014, International journal of molecular sciences.

[149]  J. Beijnen,et al.  ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy , 2014, Clinical Cancer Research.

[150]  O. Ogunshola,et al.  Cell‐specific blood–brain barrier regulation in health and disease: a focus on hypoxia , 2014, British journal of pharmacology.

[151]  T. Davis,et al.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? , 2014, Current pharmaceutical design.

[152]  H. Nakshatri,et al.  Angiopoietin‐2 mediates blood–brain barrier impairment and colonization of triple‐negative breast cancer cells in brain , 2014, The Journal of pathology.

[153]  Xiaoyang Xu,et al.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.

[154]  R. Komotar,et al.  The role of Gliadel wafers in the treatment of high-grade gliomas , 2013, Expert review of anticancer therapy.

[155]  B. Rosen,et al.  Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation , 2013, Proceedings of the National Academy of Sciences.

[156]  Yasuyoshi Watanabe,et al.  64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer , 2013, The Journal of Nuclear Medicine.

[157]  R. Jain,et al.  Strategies for advancing cancer nanomedicine. , 2013, Nature materials.

[158]  H. D. de Vries,et al.  Blood-brain barrier regulation , 2013, Tissue barriers.

[159]  A. Prat,et al.  Glial influence on the Blood Brain Barrier , 2013, Glia.

[160]  R. Kennedy.  Emerging trends in in vivo neurochemical monitoring by microdialysis. , 2013, Current opinion in chemical biology.

[161]  Weian Zhao,et al.  From Blood to the Brain: Can Systemically Transplanted Mesenchymal Stem Cells Cross the Blood-Brain Barrier? , 2013, Stem cells international.

[162]  Z. Ram,et al.  Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial. , 2013, The Lancet. Oncology.

[163]  R. Lonser,et al.  Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms. , 2013, Journal of neurosurgery.

[164]  I. Weissman,et al.  Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies , 2013, Nature Medicine.

[165]  S-M Huang,et al.  Why Clinical Modulation of Efflux Transport at the Human Blood–Brain Barrier Is Unlikely: The ITC Evidence‐Based Position , 2013, Clinical pharmacology and therapeutics.

[166]  B. Tannous,et al.  Advances in stem cell therapy against gliomas. , 2013, Trends in molecular medicine.

[167]  N. Abbott.  Blood–brain barrier structure and function and the challenges for CNS drug delivery , 2013, Journal of Inherited Metabolic Disease.

[168]  R. McLendon,et al.  Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth , 2013, Cell.

[169]  Atique U. Ahmed,et al.  Drug-Loaded Nanoparticle Systems And Adult Stem Cells: A Potential Marriage For The Treatment Of Malignant Glioma? , 2013, Oncotarget.

[170]  Bruce R. Rosen,et al.  Vessel Architectural Imaging Identifies Cancer Patient Responders to Anti-angiogenic Therapy , 2013, Nature Medicine.

[171]  T. Mikkelsen,et al.  Phase I Study of GRN1005 in Recurrent Malignant Glioma , 2013, Clinical Cancer Research.

[172]  C. Eberhart,et al.  Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model , 2013, Journal of Neuro-Oncology.

[173]  W. Pardridge,et al.  Drug Transport across the Blood–Brain Barrier , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[174]  J. Beijnen,et al.  Oral availability and brain penetration of the B-RAFV600E inhibitor vemurafenib can be enhanced by the P-GLYCOprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar. , 2012, Molecular pharmaceutics.

[175]  R. Jain,et al.  Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases , 2012, Proceedings of the National Academy of Sciences.

[176]  J. Sarkaria,et al.  Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents , 2012, Molecular Cancer Therapeutics.

[177]  Robert Langer,et al.  Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model. , 2012, Biomaterials.

[178]  Mickael Tanter,et al.  Dynamic Study of Blood–Brain Barrier Closure after its Disruption using Ultrasound: A Quantitative Analysis , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[179]  Natalia Vykhodtseva,et al.  Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. , 2012, Cancer research.

[180]  Jeremy Seto,et al.  Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. , 2012, The Journal of clinical investigation.

[181]  Feng-Yi Yang,et al.  Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[182]  J. Sarkaria,et al.  The role of LAT1 in 18F-DOPA uptake in malignant gliomas , 2012, Journal of Neuro-Oncology.

[183]  J. Polli,et al.  Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer , 2011, Pharmaceutical Research.

[184]  C. Betsholtz,et al.  Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.

[185]  W. Hickey,et al.  Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model , 2011, ASN neuro.

[186]  Sagar Agarwal,et al.  Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain , 2011, Expert Reviews in Molecular Medicine.

[187]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[188]  H. Gendelman,et al.  Cell-mediated drug delivery , 2011, Expert opinion on drug delivery.

[189]  S. Grossman,et al.  Tissue concentration of systemically administered antineoplastic agents in human brain tumors , 2011, Journal of Neuro-Oncology.

[190]  J. Simes,et al.  Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy , 2010, Journal of Clinical Neuroscience.

[191]  H. Gendelman,et al.  Cell-Mediated Drugs Delivery , 2011 .

[192]  B. Barres,et al.  Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.

[193]  Bengt R. Johansson,et al.  Pericytes regulate the blood–brain barrier , 2010, Nature.

[194]  Hua Su,et al.  Essential Regulation of CNS Angiogenesis by the Orphan G Protein–Coupled Receptor GPR124 , 2010, Science.

[195]  Berislav V. Zlokovic,et al.  Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.

[196]  Emmanuel L Barbier,et al.  Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media. , 2010, Radiology.

[197]  P. Steeg,et al.  Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer , 2010, Clinical Cancer Research.

[198]  Heinrich Lanfermann,et al.  Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas , 2010, The Lancet Neurology.

[199]  P. Beauchesne.  Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours. , 2010, The Lancet. Oncology.

[200]  Qingcheng Mao,et al.  Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). , 2010, Current drug metabolism.

[201]  W. Mason,et al.  Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[202]  L. Roux,et al.  Over Astroglial Networks: a Step Further in Neuroglial and Gliovascular Interactions , 2022 .

[203]  M. Ono,et al.  Disruption of the blood brain barrier by brain metastases of triple‐negative and basal‐type breast cancer but not HER2/neu‐positive breast cancer , 2010, Cancer.

[204]  Jochen Herms,et al.  Real-time imaging reveals the single steps of brain metastasis formation , 2010, Nature Medicine.

[205]  Yao-Sheng Tung,et al.  Molecules of various pharmacologically-relevant sizes can cross the ultrasound-induced blood-brain barrier opening in vivo. , 2010, Ultrasound in medicine & biology.

[206]  Michael M. Schmidt,et al.  A modeling analysis of the effects of molecular size and binding affinity on tumor targeting , 2009, Molecular Cancer Therapeutics.

[207]  Benjamin J Vakoc,et al.  Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging , 2009, Nature Medicine.

[208]  U. Bogdahn,et al.  RNOP-09: Pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma - a phase II study , 2009, BMC Cancer.

[209]  P. Wen,et al.  A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients. , 2009, Cancer research.

[210]  William A Banks,et al.  Characteristics of compounds that cross the blood-brain barrier , 2009, BMC neurology.

[211]  R. Jain,et al.  Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[212]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[213]  Masahiro Inoue,et al.  Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. , 2009, Cancer cell.

[214]  R. Greil,et al.  Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer , 2009, Clinical Cancer Research.

[215]  A. T. Argaw,et al.  VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown , 2009, Proceedings of the National Academy of Sciences.

[216]  J. Mathis,et al.  Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma , 2008, Stem cells.

[217]  Nathalie Arbour,et al.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.

[218]  Anna Seelig,et al.  The Role of Size and Charge for Blood–Brain Barrier Permeation of Drugs and Fatty Acids , 2007, Journal of Molecular Neuroscience.

[219]  W. Löscher,et al.  The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses , 2007, Clinical Cancer Research.

[220]  E. Seifried,et al.  Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. , 2006, Blood.

[221]  C. Brosnan,et al.  IL-1β Regulates Blood-Brain Barrier Permeability via Reactivation of the Hypoxia-Angiogenesis Program1 , 2006, The Journal of Immunology.

[222]  Charles Nicholson,et al.  In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[223]  M. Gumbleton,et al.  Endocytosis at the blood–brain barrier: From basic understanding to drug delivery strategies , 2006, Journal of drug targeting.

[224]  U. Bogdahn,et al.  Pegylated liposomal doxorubicin‐efficacy in patients with recurrent high‐grade glioma , 2004, Cancer.

[225]  Glyn Johnson,et al.  Dynamic, contrast‐enhanced perfusion MRI in mouse gliomas: Correlation with histopathology , 2003, Magnetic resonance in medicine.

[226]  Dai Fukumura,et al.  Dissecting tumour pathophysiology using intravital microscopy , 2002, Nature Reviews Cancer.

[227]  R. Jain,et al.  Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[228]  K. Hynynen,et al.  Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. , 2001, Radiology.

[229]  P. Black,et al.  Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[230]  D. Groothuis,et al.  The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. , 2000, Neuro-oncology.

[231]  A. Schinkel,et al.  P-Glycoprotein, a gatekeeper in the blood-brain barrier. , 1999, Advanced drug delivery reviews.

[232]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[233]  R. K. Jain,et al.  Interstitial fluid pressure in intracranial tumours in patients and in rodents. , 1997, British Journal of Cancer.

[234]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[235]  R A Patchell,et al.  Brain metastases. , 1991, Neurologic clinics.